| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |